NCT07288762Not yet recruiting
Gonadal Function in Thalassemic Patient
Gonadal Function in Boys With Transfusion Depandant Beta Thalassemia
Source: ClinicalTrials.gov · Last updated 17 Dec 2025
Brief summary (registry, in English)
Patient with transfusion depandant beta thalassemia with accumulation of iron in their body affect pituitary gland and gonades lead to impaired their functions .
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 22 Nov 2025
- Start date
- 7 Dec 2025
- Primary completion date
- 1 Apr 2026
- Lead sponsor
- Sohag University
- Diseases
- Thalassaemia
- NCT number
- NCT07288762
What you commit to
- Study type: Observational
- Planned participants: 80
- From 7 Dec 2025 to the primary completion date, 1 Apr 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- associated with another disease
Age
- age below 10 year old age or above 18 year old age
Who the study is looking for
- transfusion depandant beta thalassemia
- age 10 to 18 year old age
Age in the registry: 10 years to 18 years · Sex: Male · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.